p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancerJinghui Liu, Xiaoqi Liu, Yifan Kong et al.|Oncogene|2020Cited by 114
Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC)Yifan Kong, Xiaoqi Liu, Lijun Cheng et al.|Journal of Biological Chemistry|2018Cited by 103
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cellsElia Farah, Xiaoqi Liu, Tim Ratliff et al.|Journal of Biological Chemistry|2019Cited by 69